On Stockhead today, coal prices and the ‘once in a generation’ opportunity, all about All In Sustaining Costs, and is Clarity’s cancer-hunting future clear?

But first … the day ahead. 

 

TRADING HALTS

The following companies are in trading halts and are expected out in the next two trading days: 

Monday

Environmental Clean Technologies (ASX:ECT) – cleansing notice lodging
Barra Resources (ASX:BAR) – capital raising
Nutritional Growth Solutions (ASX:NGS) – capital raising
Ragusa Minerals (ASX:RAS) – lodging prospectus

Tuesday

Nanoveu (ASX:NVU) – capital raising
Norwest Energy (ASX:NWE) – capital raising
Beamtree Holdings (ASX:BMT) – acquisition
Valor Resources (ASX:VAL) – exploration results
BWX (ASX:BWX) – corporate transaction

 

MARKETS

Gold: $US1,818.29 ($2,488.32) (+1.46%)

Silver: $US24.03 ($32.88) (+2.07%)

Oil (WTI): $US68.57 (-0.25%)

Oil (Brent): $US72.70 (+2.29%)

Coal: $US170.95 (-0.03%)

Iron 62pc Fe: $US159.68 (+0.03%)

AUD/USD: $US0.7307 (-0.07%)

Bitcoin: $US48,947.92 (+0.44%)

 

WHAT GOT YOU TALKING LAST WEEK?

Rubidium carbonate’s crazy high price at $1 million per tonne caught your eye.


To keep up to date with Stockhead coverage, follow our Twitter page or sign up to our members-only Facebook group here.

For all you crypto lovers Stockhead’s Cryptohead Facebook group is the place to share your views, insights, tips and ideas.

Also, be sure to check in at 10.20am each day for our daily ‘10 at 10’ column — a live summary of winners & losers at the opening bell.

 

LAST WEEK’S WINNERS

Scroll or swipe to reveal table. Click headings to sort.

MGC Pharmaceuticals (ASX:MXC) rose after signing a US$24 million supply agreement – its first such deal in the USA.

Rhinomed (ASX:RNO) said it had completed development of the world’s first nasal swab designed for children.

Recently listed explorer Flynn Gold (ASX:FG1) rose after an exploration update.

And law firm Slater and Gordon (ASX:SGH) rose off the back of its financial results.

 

LAST WEEK’S LOSERS

Scroll or swipe to reveal table. Click headings to sort.

AJ Lucas (ASX:AJL)Mayne Pharma (ASX:MYX) and Integral Diagnostics (ASX:IDX) all fell on annual results.